ST. PAUL, Minn.--(BUSINESS WIRE)--Minnetronix, a leading medical technology and innovation company, today announced that Mark Wagner has joined the company’s board of directors. Wagner has more than 30 years of experience in the medical device industry, most recently serving as president and CEO of Minnesota based Celleration, Inc., until its acquisition by Alliqua in May 2015. He continues to serve on Alliqua’s board of directors.
“Mark brings a wealth of valuable knowledge and insight from his substantial experience building and leading successful medical device companies. He will be a great addition to our board,” said Rich Nazarian, president and CEO of Minnetronix.
Prior to Celleration, Wagner co-founded and served as board chairman for Orasi Medical, a University of Minnesota spinout developing diagnostic tools for neurological diseases. Additionally, he served as president and CEO for both Reshape Medical and ProVation Medical, and as chairman and CEO of Survivalink. Wagner’s experience also includes a number of executive leadership positions at Nellcor Puritan Bennett. He began his career at GE Healthcare where he worked in marketing, business development and finance.
“It’s an exciting time to join the Minnetronix team,” said Wagner. “Minnetronix has built a solid foundation and reputation as a medical technology company, and I look forward to contributing to the company as it continues to grow and expand its business portfolio.”
In addition to completing executive leadership and corporate training programs, Wagner earned a Bachelor of Science degree in Business Administration from the University of Southern California.
Minnetronix is a medical technology and innovation company with deep expertise in electronic and electromechanical devices. Founded in 1996, the company creates new technologies and therapies that solve unmet clinical and business needs for patients and medical device companies. Minnetronix is FDA Registered and ISO 13485 Certified.